» Articles » PMID: 26693912

The Clinical Status of Radiation Therapy in Korea in 2009 and 2013

Overview
Specialty Oncology
Date 2015 Dec 24
PMID 26693912
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The purpose of this study is to estimate the clinical status of radiation therapy (RT) in Korea.

Materials And Methods: We analyzed open claims data from the Health Insurance Review and Assessment Service (HIRA). The subjects were patients with malignant neoplasms who had procedure codes concerning RT in 2009 and 2013.

Results: The total numbers of patients who underwent RT in 2009 and 2013 were 42,483 and 56,850, respectively. The numbers of men and women were 20,012 and 22,471 in 2009 and 26,936 and 29,914 in 2013, respectively. The five most frequent RT sites were metastatic, breast, gastrointestinal, thoracic, and gynecologic cancers in 2009, and metastatic, breast, gastrointestinal, thoracic and head and neck cancers in 2013. The three leading types of cancer among men were metastatic, gastrointestinal, and thoracic, and breast, metastatic, and gynecologic among women. According to age, the most common treatment site was the central nervous system for those aged 20 years or less, the breast for those in their 30s to 50s, and metastatic sites for those in their 60s or older.

Conclusion: Data from this study provide an overview of the clinical status of RT in Korea.

Citing Articles

Patterns of definitive radiotherapy practice for cervical cancer in South Korea: a survey endorsed by the Korean Radiation Oncology Group (KROG 20-06).

Kim N, Park W J Gynecol Oncol. 2021; 32(3):e43.

PMID: 33825358 PMC: 8039174. DOI: 10.3802/jgo.2021.32.e43.


Estimation of the medical need for carbon-ion radiotherapy in Korea.

Cho I, Seo Y, Jung W, Kim M J Radiat Res. 2018; 59(5):588-592.

PMID: 29939311 PMC: 6151627. DOI: 10.1093/jrr/rry046.


A Survey of Radiation Therapy Utilization in Korea from 2010 to 2016: Focusing on Use of Intensity-Modulated Radiation Therapy.

Rim C, Lee J, Kim W, Yang D, Yoon W, Koom W J Korean Med Sci. 2018; 33(9):e67.

PMID: 29441739 PMC: 5811661. DOI: 10.3346/jkms.2018.33.e67.


The Clinical Utilization of Radiation Therapy in Korea between 2011 and 2015.

Seo Y, Kim M, Kang J, Jang W, Kim H, Cho C Cancer Res Treat. 2017; 50(2):345-355.

PMID: 28449574 PMC: 5912150. DOI: 10.4143/crt.2017.096.


The clinical utilization of radiation therapy in Korea between 2009 and 2013.

Kang J, Kim M, Jang W, Seo Y, Kim H, Cho C Radiat Oncol J. 2016; 34(2):88-95.

PMID: 27381419 PMC: 4938344. DOI: 10.3857/roj.2016.01753.

References
1.
Ji Y, Kim M, Jung H, Yoo S, Cho C . Clinical characteristics of radiation oncology in Korea during past 10 years. J Korean Med Sci. 2009; 24(6):1165-9. PMC: 2775868. DOI: 10.3346/jkms.2009.24.6.1165. View

2.
Jung K, Won Y, Kong H, Oh C, Cho H, Lee D . Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2012. Cancer Res Treat. 2015; 47(2):127-41. PMC: 4398120. DOI: 10.4143/crt.2015.060. View

3.
Jung K, Won Y, Kong H, Oh C, Seo H, Lee J . Prediction of cancer incidence and mortality in Korea, 2013. Cancer Res Treat. 2013; 45(1):15-21. PMC: 3629359. DOI: 10.4143/crt.2013.45.1.15. View

4.
Lee T, Kim S, Cho H, Lee J . The incidence of thyroid cancer is affected by the characteristics of a healthcare system. J Korean Med Sci. 2012; 27(12):1491-8. PMC: 3524428. DOI: 10.3346/jkms.2012.27.12.1491. View

5.
Jung K, Park S, Kong H, Won Y, Lee J, Seo H . Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2009. Cancer Res Treat. 2012; 44(1):11-24. PMC: 3322196. DOI: 10.4143/crt.2012.44.1.11. View